论文部分内容阅读
近30年来,肺癌新的治疗理念、手术方式、化疗药物不断涌现,靶向药物也层出不穷,治疗费用越来越高,但肺癌患者5年生存率仅从13%提高到16%,并没有较大幅度的改观。我对晚期肿瘤患者的综合治疗进行了大量的临床实践和深入的研究,打破了国
In the past 30 years, new treatments for lung cancer, surgical methods, and chemotherapy drugs have continued to emerge, targeted drugs have emerged in an endless stream, and the cost of treatment has increased. However, the 5-year survival rate of lung cancer patients has only increased from 13% to 16%. A substantial change. I have carried out a lot of clinical practice and in-depth research on the comprehensive treatment of patients with advanced cancer and broke the country.